This finding supports previous findings in this cohort of patients, in which E‐cadherin tumour expression was significantly reduced in patients treated with docetaxel (Puhr et al., 2012), thereby providing clinical evidence for the link of ZEB1 and E‐cadherin expression following docetaxel treatment. This evidence concerns the gene ZEB1 and neoplasm.